• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从脑肿瘤组织切片和流式细胞术获得的溴脱氧尿苷标记指数的比较。

Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.

作者信息

Nagashima T, Hoshino T, Cho K G, Senegor M, Waldman F, Nomura K

机构信息

Brain Tumor Research Center, University of California, San Francisco.

出版信息

J Neurosurg. 1988 Mar;68(3):388-92. doi: 10.3171/jns.1988.68.3.0388.

DOI:10.3171/jns.1988.68.3.0388
PMID:3278075
Abstract

Sixteen patients with brain tumors were given a 30- to 60-minute intravenous infusion of bromodeoxyuridine (BUdR), 200 mg/sq m. Grossly viable fragments were taken from the biopsied tumor specimens and divided into two portions. One portion was dissociated into single cells, stained both with fluorescein isothiocyanate (FITC) using anti-BUdR monoclonal antibody as the first antibody and with propidium iodide (for deoxyribonucleic acid), and analyzed by flow cytometry (FCM). The labeling index (LI) was calculated as the number of FITC-labeled cells expressed as a percentage of the total number of cells analyzed. The other portion was fixed in 70% ethanol, embedded in paraffin, sectioned, and stained with immunoperoxidase using anti-BUdR monoclonal antibody as the first antibody. The LI of these tissue sections was calculated in two ways: from selected areas in which the labeled cells were evenly distributed and from the entire tissue section. The LI's obtained by FCM correlated closely with those from the entire tissue sections (r = 0.99, p less than 0.000001) and were usually lower than LI's from selected areas of tissue sections. The LI's determined by FCM also correlated well with the LI's from selected areas of tissue sections (r = 0.82, p less than 0.00012), despite the difference in values between them. Thus, the FCM-derived LI and the tissue LI can both provide useful information for predicting the biological malignancy of individual tumors and for designing treatment regimens for individual patients with brain tumors; however, different standards should be used to interpret the LI's obtained by these two methods.

摘要

16例脑肿瘤患者接受了30至60分钟的静脉输注溴脱氧尿苷(BUdR),剂量为200mg/平方米。从活检的肿瘤标本中获取大体上有活力的碎片,并分成两份。一份解离成单细胞,先用抗BUdR单克隆抗体作为一抗用异硫氰酸荧光素(FITC)染色,再用碘化丙啶(用于脱氧核糖核酸)染色,然后通过流式细胞术(FCM)进行分析。标记指数(LI)计算为FITC标记细胞的数量占所分析细胞总数的百分比。另一份固定在70%乙醇中,石蜡包埋,切片,并用抗BUdR单克隆抗体作为一抗进行免疫过氧化物酶染色。这些组织切片的LI通过两种方式计算:从标记细胞均匀分布的选定区域以及从整个组织切片计算。通过FCM获得的LI与整个组织切片的LI密切相关(r = 0.99,p < 0.000001),并且通常低于组织切片选定区域的LI。尽管它们之间的值存在差异,但通过FCM确定的LI与组织切片选定区域的LI也具有良好的相关性(r = 0.82,p < 0.00012)。因此,FCM得出的LI和组织LI都可为预测个体肿瘤的生物学恶性程度以及为个体脑肿瘤患者设计治疗方案提供有用信息;然而,应使用不同的标准来解释通过这两种方法获得的LI。

相似文献

1
Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.从脑肿瘤组织切片和流式细胞术获得的溴脱氧尿苷标记指数的比较。
J Neurosurg. 1988 Mar;68(3):388-92. doi: 10.3171/jns.1988.68.3.0388.
2
[Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].[通过细胞DNA含量和掺入的溴脱氧尿苷量的双变量流式细胞术测量对人脑肿瘤进行细胞动力学分析]
No To Shinkei. 1989 Apr;41(4):383-90.
3
Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.人类胶质瘤溴脱氧尿苷标记指数的预后意义
J Neurosurg. 1989 Sep;71(3):335-41. doi: 10.3171/jns.1989.71.3.0335.
4
In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
J Neurosurg. 1986 Mar;64(3):453-9. doi: 10.3171/jns.1986.64.3.0453.
5
[A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].[脑肿瘤细胞动力学研究综述,特别参考抗溴脱氧尿苷单克隆抗体法]
No Shinkei Geka. 1984 Aug;12(9):1007-18.
6
Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling.
J Neurosurg. 1986 Dec;65(6):790-4. doi: 10.3171/jns.1986.65.6.0790.
7
Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
J Neurosurg. 1989 Mar;70(3):379-84. doi: 10.3171/jns.1989.70.3.0379.
8
Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Cytometry. 1985 Nov;6(6):627-32. doi: 10.1002/cyto.990060619.
9
Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients.脑肿瘤患者体外溴脱氧尿苷标记指数和DNA非整倍体与生存或复发的相关性。
J Neurosurg. 1990 Sep;73(3):396-400. doi: 10.3171/jns.1990.73.3.0396.
10
Prognostic implications of the proliferative potential of low-grade astrocytomas.
J Neurosurg. 1988 Dec;69(6):839-42. doi: 10.3171/jns.1988.69.6.0839.

引用本文的文献

1
DNA ploidy and S-phase in recurrent astrocytomas: a retrospective study by flow cytometry of deparaffinized specimens.复发性星形细胞瘤的DNA倍体和S期:一项对脱蜡标本进行流式细胞术分析的回顾性研究。
J Neurooncol. 1996 Oct;30(1):37-45. doi: 10.1007/BF00177441.
2
The application of 5-bromodeoxyuridine in the management of CNS tumors.5-溴脱氧尿苷在中枢神经系统肿瘤治疗中的应用。
J Neurooncol. 1994;20(1):81-95. doi: 10.1007/BF01057964.
3
Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.脑恶性胶质瘤的化疗:十年经验回顾
Acta Neurochir (Wien). 1990;103(1-2):35-46. doi: 10.1007/BF01420190.
4
Rapid estimation of the proliferating index of brain tumours.
J Neurooncol. 1990 Jun;8(3):245-53. doi: 10.1007/BF00177357.
5
DNA in human glioblastomas. A flow-fluorescence cytometrical examination of 96 tumors.人类胶质母细胞瘤中的DNA。96例肿瘤的流式荧光细胞术检查。
Neurosurg Rev. 1990;13(2):123-39. doi: 10.1007/BF00383653.
6
A study on the biological behavior of human brain tumors. Part I. Arachidonic acid metabolism and DNA content.一项关于人脑肿瘤生物学行为的研究。第一部分。花生四烯酸代谢与DNA含量。
J Neurooncol. 1991 Jun;10(3):233-40. doi: 10.1007/BF00177535.
7
Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.经颈动脉给予嘧啶亚硝脲后大鼠脑肿瘤中溴脱氧尿苷标记指数的调节
J Neurooncol. 1992 Nov;14(3):201-5. doi: 10.1007/BF00172595.